Recent articles
Takeda Pharmaceutical Announces a Plasma-Derived Coronavirus Therapy
Plasma-derived therapies have proven effective in the treatment of severe acute viral respiratory infections.
Vir Biotechnology and Alnylam Join the Fight Against COVID-19
The two biotechs are expanding their existing collaboration with the goal of developing an antiviral treatment for the novel coronavirus.
3 Small-Caps That Are Soaring Because of Coronavirus Panic
Some of the top stocks in 2020 are the companies that are fighting the coronavirus.
Vir Biotechnology and WuXi Biologics to Collaborate on COVID-19 Treatment
News that the two biotechs are working together on monoclonal antibody treatments for the coronavirus has excited investors.
Ionis Pharmaceuticals' Revenues Rose 85% in 2019
The biotechnology company's license fees increased almost 400% to $490 million.
U.S. Health Official Warns: COVID-19 Will Hit the United States
Americans should prepare for the possibility that their lives will be disrupted due to the pandemic, says the CDC's Nancy Messonnier.
Intercept Pharmaceuticals Reports 40% Revenue Growth for 2019
The company's lead drug, Ocaliva, brought in $249.6 million last year.
These 2 Stocks Could Be 2020's Best Profit Opportunities
How do we find the top stock of 2020? The best performers in 2019 offer some clues.
A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward
A host of major healthcare companies and drug retailers are collaborating on a system to combat fake drugs.
Anika Therapeutics Beats Revenue and Earnings Estimates
A recent acquisition and a new product launch held back earnings, but should be beneficial over the long term.
3 High-Growth Stocks Whose Gains Are Just Getting Started
These young companies have already delivered big returns for their shareholders, and there's every reason to expect more to come.
Vir Bio Identifies 2 Antibodies That Might Stop Coronavirus
Antibody-based treatments can be used both to protect people from infection and to treat those already affected.
Ionis Receives Orphan Drug Designation From EMA
The company is advancing a new treatment for people with Alexander disease.
Myriad Genetics CEO Mark Capone Resigns
The molecular diagnostics company also delivered an earnings miss, and its stock plunged.
Alnylam Beats Revenue Estimates, but Misses on Earnings
Shares of the genetic disease specialist were essentially flat in late afternoon trading.
Abiomed Crushed Its Earnings Estimates, but the Market Wasn't Impressed
The medical device maker's stock dropped 9%, then recovered.
3 Top Small-Cap Stocks to Buy in February
An insurance-shopping portal, a U.K. software company, and a Brazilian medical school operator all have potential for outsize returns.
Why Did Karuna Therapeutics Pop 26% in January?
The volatile biotech has been up and down since its massive gain back in November.
2 Top Healthcare Stocks to Buy Right Now
These two biotechs have major drugs that should be hitting the market soon.
Why Sea Stock Was Up 12.5% in January
The Singapore internet giant might be entering the banking business.